Efficacy and safety of first-line treatments for patients with advanced hepatocellular carcinoma: A systematic review and network meta-analysis. This is an ASCO Meeting Abstract from the 2023 ASCO ...
The development of antibody-based therapies has allowed the achievement of the first valid targeted therapies for neoplastic disease.1 Specifically, the direct administration of anti-tumor monoclonal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results